delta-9
Hemp delta-9 is legal in Utah only in UDAF-registered ingestibles at 5 mg per serving and 150 mg per package. Adult use is not legal. What changes Dec 11.
Last reviewed: September 13, 2026
Restricted. Hemp-derived delta-9 THC products are allowed in Utah only as ingestible cannabinoid products that are registered with the Utah Department of Agriculture and Food, sold through licensed retailers, and that meet the 5 mg total THC per serving and 150 mg per package caps. Marijuana-derived delta-9 THC is controlled and available only through the Utah medical cannabis program run by the Utah Department of Health and Human Services. Adult-use cannabis is not legal.
UDAF runs the industrial hemp program under Utah Code Title 4 Ch. 41 and the cannabinoid product registration regime under Ch. 41a. DHHS runs the medical cannabis program built on Proposition 2 (2018) as substantially amended by the legislature; beginning July 1, 2025 medical providers no longer need separate QMP registration and need only complete the recommended continuing education to certify and recommend medical cannabis. The patient card fee from July 1, 2025 is $8.
HB 227 (2023) created the cannabinoid product registration framework and the 5 mg per serving and 150 mg per package caps for products that exceed the background THC thresholds. HB 54 (2025), signed March 24, 2025 and effective May 7, 2025, applied total-THC math across all THC isomers and analogs and excluded chemically converted intoxicating cannabinoids from the lawful hemp definition.
Hemp at the plant stage must remain below 0.3 percent combined THC and THC analogs on a dry-weight basis. Finished cannabinoid products exceeding 0.3 percent combined THC and THC analogs on a dry-weight basis, or containing more than 10 percent of total cannabinoid content as THC and THC analogs, fall under the UDAF registration regime.
Registered ingestible cannabinoid products are capped at 5 mg total THC per serving and 150 mg per package. Total THC is calculated as delta-9 plus any THC analog after decarboxylation. Inhalable cannabinoid products are restricted, must carry mandatory health warnings, and must register; smokable hemp flower and chemically converted intoxicating cannabinoid vapes are not registrable.
Marijuana-derived delta-9 THC is a Schedule I controlled substance under Utah Code §58-37 with carve-outs only for the DHHS medical cannabis program and registered medical providers and pharmacies.
UDAF inspection activity ramped up after HB 54 took effect on May 7, 2025. The focus has been on unregistered cannabinoid products, products that exceed the 5 mg per serving cap, and beverages or edibles relying on chemically converted cannabinoids. Enforcement has included stop-sale orders, civil penalties under §4-41a-1101, and license actions. The DHHS medical cannabis program continued normal pharmacy operations through the same period; the 2025 provider-registration change has expanded access without changing dispensing rules.
Compliant hemp-derived delta-9 ingestibles, including some beverages, gummies, and tinctures, are available from UDAF-registered retailers within the 5 mg per serving and 150 mg per package limits. Marijuana flower and higher-potency products are only available with a DHHS medical cannabis card from a licensed medical cannabis pharmacy. Hemp-derived delta-9 shows up on standard drug tests.
HB 469 (2026), a cannabinoid-amendments bill, failed on the House floor on March 6, 2026, leaving the HB 54 framework unchanged. At the federal level, the hemp redefinition in Section 781 of last year's agriculture appropriations act — which measures hemp by total THC and caps finished products at 0.4 mg total THC per container — was delayed by Public Law 119-103, signed September 2, 2026. Most of the redefinition now takes effect December 11, 2026; only cannabinoids "not capable of being naturally produced" by the plant keep the original November 12, 2026 date. December 11 is also the next federal funding deadline, so the date can move again. The federal per-container cap is dramatically tighter than Utah's 150 mg per-package cap on ingestibles, which will narrow most existing hemp-derived delta-9 product lines well before it lands.
Is hemp-derived delta-9 THC legal in Utah? Yes, in registered ingestible cannabinoid products within the 5 mg per serving and 150 mg per package caps, sold through UDAF-licensed retailers.
Is marijuana-derived delta-9 legal in Utah? Only through the DHHS medical cannabis program with a valid patient card. Otherwise it remains a Schedule I controlled substance.
Are delta-9 vapes or smokable hemp legal in Utah? No. Smokable hemp flower and hemp-derived delta-9 vape products produced through chemical conversion are not registrable as cannabinoid products under HB 54 (2025).
How is total THC calculated in Utah? Delta-9 THC plus any THC analog after decarboxylation. The combined number must stay at or below the cannabinoid product caps.
What is the patient card fee for the Utah medical cannabis program? From July 1, 2025, the patient card fee is $8 and providers no longer need separate QMP registration to certify patients.
Can I order delta-9 gummies and have them shipped to Utah? Only if the product is registered with UDAF and meets the 5 mg per serving and 150 mg per package limits. Out-of-state shipments exceeding those limits violate state law.
When does the federal 0.4 mg per container cap take effect? December 11, 2026 for most products. Public Law 119-103, signed September 2, 2026, delayed most of the federal hemp redefinition from November 12 to December 11; cannabinoids the plant cannot naturally produce keep the November 12 date. Utah products must comply with both the state and federal regimes after that date.
This page is provided for informational purposes by ComplyAssistAI LLC and is not legal advice. Hemp and cannabis law in Utah changes frequently. For business compliance questions, consult a Utah-licensed cannabis attorney. Find one in our Cannabis Lawyer Directory.
Restricted
Utah HB 54 (2025); HB 227 (2023); Utah Code §4-41a; §58-37 Controlled Substances Act; medical cannabis program at DHHS
Hemp-derived delta-9 THC capped at 5 mg total THC per serving and 150 mg per package in UDAF-registered ingestible cannabinoid products. Inhalable cannabinoid products restricted.
Yes
